1. Home
  2. EGY vs ORGO Comparison

EGY vs ORGO Comparison

Compare EGY & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VAALCO Energy Inc.

EGY

VAALCO Energy Inc.

HOLD

Current Price

$5.33

Market Cap

652.7M

Sector

Energy

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.50

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EGY
ORGO
Founded
1985
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
652.7M
348.6M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
EGY
ORGO
Price
$5.33
$2.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.30
$8.50
AVG Volume (30 Days)
1.7M
1.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
4.51%
N/A
EPS Growth
N/A
1600.00
EPS
N/A
0.15
Revenue
$359,272,000.00
$564,169,000.00
Revenue This Year
$8.78
N/A
Revenue Next Year
$29.81
$26.27
P/E Ratio
N/A
$17.00
Revenue Growth
N/A
17.04
52 Week Low
$3.14
$2.21
52 Week High
$6.72
$7.08

Technical Indicators

Market Signals
Indicator
EGY
ORGO
Relative Strength Index (RSI) 37.21 46.18
Support Level $4.97 $2.26
Resistance Level $5.38 $2.57
Average True Range (ATR) 0.25 0.16
MACD -0.13 0.07
Stochastic Oscillator 14.33 63.62

Price Performance

Historical Comparison
EGY
ORGO

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: